Sonja Alsemgeest Swanson, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mendelian Randomization Analysis | 19 | 2024 | 1010 | 6.040 |
Why?
|
Causality | 14 | 2024 | 1244 | 3.550 |
Why?
|
Firearms | 9 | 2024 | 626 | 2.590 |
Why?
|
Suicide | 11 | 2024 | 1602 | 1.900 |
Why?
|
Data Interpretation, Statistical | 10 | 2024 | 2691 | 1.340 |
Why?
|
Dementia | 5 | 2024 | 2684 | 1.200 |
Why?
|
Binge-Eating Disorder | 10 | 2018 | 147 | 1.020 |
Why?
|
Bulimia Nervosa | 13 | 2018 | 205 | 0.970 |
Why?
|
Selection Bias | 4 | 2024 | 359 | 0.910 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2023 | 2517 | 0.840 |
Why?
|
Epidemiologic Methods | 2 | 2019 | 1336 | 0.820 |
Why?
|
Models, Statistical | 8 | 2024 | 5081 | 0.600 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 9 | 2016 | 1990 | 0.570 |
Why?
|
Bulimia | 5 | 2016 | 400 | 0.540 |
Why?
|
Sigmoidoscopy | 1 | 2015 | 151 | 0.490 |
Why?
|
Epidemiologic Research Design | 2 | 2021 | 368 | 0.480 |
Why?
|
Humans | 114 | 2024 | 761208 | 0.430 |
Why?
|
Antidepressive Agents | 5 | 2016 | 2893 | 0.420 |
Why?
|
Comparative Effectiveness Research | 2 | 2015 | 709 | 0.420 |
Why?
|
Genetic Variation | 5 | 2021 | 6567 | 0.410 |
Why?
|
Random Allocation | 1 | 2017 | 2393 | 0.400 |
Why?
|
Statistics as Topic | 2 | 2015 | 2359 | 0.390 |
Why?
|
Interview, Psychological | 7 | 2015 | 809 | 0.380 |
Why?
|
Smoking Cessation | 1 | 2023 | 2056 | 0.380 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2013 | 321 | 0.370 |
Why?
|
Ownership | 3 | 2024 | 340 | 0.360 |
Why?
|
Body Image | 4 | 2017 | 639 | 0.360 |
Why?
|
Psychiatric Status Rating Scales | 9 | 2016 | 6011 | 0.350 |
Why?
|
Research Report | 1 | 2013 | 367 | 0.340 |
Why?
|
Self-Injurious Behavior | 6 | 2016 | 566 | 0.330 |
Why?
|
Probability | 3 | 2024 | 2478 | 0.330 |
Why?
|
Pregnancy Complications | 3 | 2022 | 2949 | 0.320 |
Why?
|
Emigration and Immigration | 1 | 2011 | 397 | 0.310 |
Why?
|
Body Weight | 8 | 2017 | 4618 | 0.310 |
Why?
|
Anorexia Nervosa | 9 | 2018 | 1361 | 0.300 |
Why?
|
Anxiety Disorders | 7 | 2016 | 2723 | 0.300 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3245 | 0.290 |
Why?
|
Public Health | 1 | 2021 | 2672 | 0.290 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 3707 | 0.290 |
Why?
|
Monte Carlo Method | 2 | 2016 | 1256 | 0.280 |
Why?
|
Gastrointestinal Diseases | 2 | 2013 | 1201 | 0.280 |
Why?
|
Female | 70 | 2024 | 392544 | 0.280 |
Why?
|
California | 4 | 2024 | 1431 | 0.270 |
Why?
|
Prevalence | 12 | 2020 | 15721 | 0.270 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2023 | 10218 | 0.270 |
Why?
|
Epidemiology | 2 | 2021 | 280 | 0.270 |
Why?
|
Cohort Studies | 17 | 2024 | 41496 | 0.260 |
Why?
|
Substance-Related Disorders | 9 | 2016 | 4413 | 0.250 |
Why?
|
Depression | 6 | 2016 | 8132 | 0.250 |
Why?
|
Research Design | 5 | 2024 | 6180 | 0.250 |
Why?
|
Guidelines as Topic | 2 | 2021 | 1385 | 0.240 |
Why?
|
Blood Pressure | 1 | 2020 | 8479 | 0.240 |
Why?
|
Pandemics | 2 | 2022 | 8663 | 0.240 |
Why?
|
Mood Disorders | 3 | 2012 | 1124 | 0.240 |
Why?
|
Mental Disorders | 7 | 2015 | 6823 | 0.240 |
Why?
|
Homicide | 2 | 2024 | 294 | 0.240 |
Why?
|
Adolescent | 35 | 2018 | 88298 | 0.240 |
Why?
|
Longitudinal Studies | 13 | 2023 | 14610 | 0.240 |
Why?
|
Suicide, Attempted | 4 | 2015 | 1402 | 0.230 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6505 | 0.220 |
Why?
|
Self Report | 2 | 2017 | 3727 | 0.220 |
Why?
|
Male | 57 | 2024 | 360693 | 0.210 |
Why?
|
Stroke | 3 | 2020 | 9721 | 0.210 |
Why?
|
Hyperphagia | 2 | 2014 | 139 | 0.210 |
Why?
|
Hypertension | 2 | 2020 | 8536 | 0.210 |
Why?
|
Sex | 1 | 2022 | 53 | 0.210 |
Why?
|
Law Enforcement | 1 | 2024 | 112 | 0.210 |
Why?
|
Pregnancy | 10 | 2023 | 29893 | 0.210 |
Why?
|
Medicaid | 1 | 2015 | 2813 | 0.190 |
Why?
|
Antidepressive Agents, Second-Generation | 2 | 2015 | 489 | 0.190 |
Why?
|
Trans Fatty Acids | 1 | 2022 | 155 | 0.190 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 3198 | 0.190 |
Why?
|
Communication | 1 | 2015 | 3872 | 0.190 |
Why?
|
Parents | 2 | 2016 | 3564 | 0.180 |
Why?
|
Pleural Effusion, Malignant | 2 | 1998 | 106 | 0.170 |
Why?
|
Registries | 1 | 2016 | 8247 | 0.170 |
Why?
|
Policy | 1 | 2023 | 506 | 0.170 |
Why?
|
Cholesterol, HDL | 2 | 2023 | 1812 | 0.170 |
Why?
|
Erythrocyte Transfusion | 1 | 2024 | 569 | 0.170 |
Why?
|
Comorbidity | 9 | 2017 | 10516 | 0.160 |
Why?
|
Drug Repositioning | 1 | 2021 | 233 | 0.160 |
Why?
|
Aged, 80 and over | 14 | 2020 | 58952 | 0.150 |
Why?
|
Hemoglobins | 1 | 2024 | 1525 | 0.150 |
Why?
|
Myocardial Infarction | 2 | 2024 | 11476 | 0.150 |
Why?
|
Middle Aged | 29 | 2024 | 220853 | 0.150 |
Why?
|
Wounds, Gunshot | 1 | 2024 | 582 | 0.150 |
Why?
|
Venules | 1 | 2018 | 161 | 0.150 |
Why?
|
United States | 19 | 2024 | 72339 | 0.150 |
Why?
|
Suicidal Ideation | 3 | 2014 | 1447 | 0.150 |
Why?
|
Goals | 1 | 2023 | 710 | 0.150 |
Why?
|
Child | 21 | 2023 | 80152 | 0.150 |
Why?
|
Adolescent Behavior | 3 | 2016 | 1188 | 0.150 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 780 | 0.140 |
Why?
|
Neoplasms | 2 | 2024 | 22140 | 0.140 |
Why?
|
Ascitic Fluid | 1 | 1997 | 189 | 0.140 |
Why?
|
Risk Factors | 14 | 2023 | 74239 | 0.140 |
Why?
|
Databases as Topic | 1 | 2019 | 473 | 0.140 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 413 | 0.140 |
Why?
|
Adult | 34 | 2024 | 221119 | 0.140 |
Why?
|
Young Adult | 21 | 2020 | 59221 | 0.130 |
Why?
|
Genome-Wide Association Study | 4 | 2023 | 12676 | 0.130 |
Why?
|
Reference Standards | 1 | 2019 | 1005 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6919 | 0.130 |
Why?
|
Biomedical Research | 1 | 2011 | 3434 | 0.130 |
Why?
|
Pericardial Effusion | 1 | 1997 | 247 | 0.130 |
Why?
|
Aged | 17 | 2024 | 169288 | 0.120 |
Why?
|
Surrogate Mothers | 1 | 2014 | 16 | 0.120 |
Why?
|
Anemia | 1 | 2024 | 1504 | 0.120 |
Why?
|
Paroxetine | 1 | 2015 | 181 | 0.120 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 306 | 0.120 |
Why?
|
Age Factors | 9 | 2019 | 18384 | 0.120 |
Why?
|
Body Size | 1 | 2017 | 463 | 0.120 |
Why?
|
Pleural Effusion | 1 | 1997 | 341 | 0.120 |
Why?
|
Checklist | 1 | 2021 | 828 | 0.120 |
Why?
|
Norway | 1 | 2015 | 499 | 0.120 |
Why?
|
Pregnancy Outcome | 3 | 2022 | 2923 | 0.120 |
Why?
|
Health Surveys | 6 | 2014 | 4037 | 0.110 |
Why?
|
Smoking | 2 | 2023 | 9055 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1111 | 0.110 |
Why?
|
Cholesterol | 1 | 2023 | 2902 | 0.110 |
Why?
|
Mastication | 1 | 2013 | 53 | 0.110 |
Why?
|
Pregnancy Rate | 2 | 2014 | 648 | 0.110 |
Why?
|
Health Services Needs and Demand | 2 | 2019 | 1401 | 0.110 |
Why?
|
Travel | 1 | 2019 | 796 | 0.110 |
Why?
|
Drug Labeling | 1 | 2015 | 248 | 0.110 |
Why?
|
Data Collection | 1 | 2022 | 3320 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 645 | 0.110 |
Why?
|
DNA Fragmentation | 1 | 2013 | 237 | 0.100 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2014 | 186 | 0.100 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2013 | 156 | 0.100 |
Why?
|
Feeding Behavior | 3 | 2013 | 3183 | 0.100 |
Why?
|
Diagnostic Self Evaluation | 1 | 2014 | 225 | 0.100 |
Why?
|
Periodicals as Topic | 1 | 2022 | 1463 | 0.100 |
Why?
|
Cross-Sectional Studies | 6 | 2017 | 26071 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2024 | 4027 | 0.090 |
Why?
|
Computer Simulation | 1 | 2024 | 6224 | 0.090 |
Why?
|
Risk Assessment | 6 | 2018 | 24021 | 0.090 |
Why?
|
Adenocarcinoma | 2 | 1998 | 6341 | 0.090 |
Why?
|
Neoplasms, Second Primary | 1 | 1998 | 1052 | 0.090 |
Why?
|
Propensity Score | 2 | 2015 | 1916 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2023 | 3608 | 0.090 |
Why?
|
Time Factors | 3 | 2019 | 39957 | 0.090 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2014 | 497 | 0.090 |
Why?
|
Body Mass Index | 5 | 2016 | 12952 | 0.090 |
Why?
|
Epidemiologic Studies | 1 | 2013 | 677 | 0.090 |
Why?
|
Mental Health Services | 2 | 2012 | 1716 | 0.090 |
Why?
|
Premature Birth | 1 | 2022 | 1784 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2015 | 1436 | 0.080 |
Why?
|
Infertility, Male | 1 | 2013 | 396 | 0.080 |
Why?
|
Obesity | 4 | 2019 | 12939 | 0.080 |
Why?
|
Drug Prescriptions | 2 | 2016 | 1668 | 0.080 |
Why?
|
Mental Competency | 1 | 2010 | 178 | 0.080 |
Why?
|
Mexico | 1 | 2011 | 757 | 0.080 |
Why?
|
Anorexia | 1 | 2010 | 152 | 0.080 |
Why?
|
Granulosa Cell Tumor | 1 | 1990 | 77 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2270 | 0.080 |
Why?
|
Depressive Disorder | 4 | 2015 | 3727 | 0.080 |
Why?
|
Spermatozoa | 1 | 2013 | 630 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3418 | 0.080 |
Why?
|
Netherlands | 3 | 2019 | 2222 | 0.080 |
Why?
|
Eating | 2 | 2013 | 1535 | 0.070 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39126 | 0.070 |
Why?
|
Prospective Studies | 10 | 2022 | 54435 | 0.070 |
Why?
|
Sex Factors | 4 | 2019 | 10553 | 0.070 |
Why?
|
Botswana | 2 | 2022 | 1049 | 0.070 |
Why?
|
Canada | 1 | 2013 | 2125 | 0.070 |
Why?
|
Heart Diseases | 1 | 2020 | 2795 | 0.070 |
Why?
|
Patient Selection | 2 | 2019 | 4246 | 0.070 |
Why?
|
Molecular Epidemiology | 1 | 2010 | 470 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 1997 | 1658 | 0.070 |
Why?
|
Child Development | 1 | 2019 | 2302 | 0.070 |
Why?
|
Anthropometry | 1 | 2012 | 1338 | 0.070 |
Why?
|
Cross-Cultural Comparison | 1 | 2010 | 634 | 0.070 |
Why?
|
Age of Onset | 2 | 2011 | 3307 | 0.070 |
Why?
|
Pilot Projects | 2 | 2021 | 8642 | 0.070 |
Why?
|
Long-Term Care | 1 | 2010 | 630 | 0.070 |
Why?
|
Research Personnel | 2 | 2023 | 588 | 0.070 |
Why?
|
Educational Status | 1 | 2014 | 2510 | 0.070 |
Why?
|
Incidence | 3 | 2020 | 21365 | 0.070 |
Why?
|
Craniocerebral Trauma | 1 | 2010 | 491 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2017 | 64681 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12052 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2018 | 3032 | 0.060 |
Why?
|
Cause of Death | 4 | 2020 | 3688 | 0.060 |
Why?
|
Child Abuse | 1 | 2013 | 1076 | 0.060 |
Why?
|
Body Composition | 1 | 2014 | 2427 | 0.060 |
Why?
|
Sensitivity and Specificity | 4 | 2013 | 14675 | 0.060 |
Why?
|
Respiratory Tract Diseases | 1 | 2010 | 748 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8003 | 0.060 |
Why?
|
Medication Adherence | 1 | 2016 | 2175 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15920 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 15308 | 0.050 |
Why?
|
Chronic Disease | 1 | 2018 | 9319 | 0.050 |
Why?
|
Severity of Illness Index | 7 | 2016 | 15841 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15520 | 0.050 |
Why?
|
Headache | 1 | 2011 | 1255 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2015 | 2046 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1997 | 4021 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5425 | 0.050 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3064 | 0.050 |
Why?
|
Disease Progression | 1 | 2018 | 13511 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2011 | 2420 | 0.050 |
Why?
|
Interleukin-10 Receptor beta Subunit | 1 | 2021 | 15 | 0.050 |
Why?
|
Weight Gain | 1 | 2011 | 2349 | 0.050 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2021 | 110 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2010 | 1167 | 0.040 |
Why?
|
Interviews as Topic | 3 | 2013 | 2697 | 0.040 |
Why?
|
Micronutrients | 1 | 2022 | 381 | 0.040 |
Why?
|
Researcher-Subject Relations | 1 | 2018 | 15 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4767 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2022 | 26199 | 0.040 |
Why?
|
Receptors, Neuropeptide Y | 1 | 1997 | 47 | 0.040 |
Why?
|
Intelligence Tests | 1 | 2019 | 503 | 0.040 |
Why?
|
Risk | 3 | 2015 | 9616 | 0.040 |
Why?
|
Prognosis | 2 | 2015 | 29687 | 0.040 |
Why?
|
Migraine Disorders | 1 | 2010 | 1701 | 0.040 |
Why?
|
Universities | 1 | 2022 | 995 | 0.030 |
Why?
|
Physicians | 1 | 2015 | 4584 | 0.030 |
Why?
|
Overweight | 3 | 2013 | 2418 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5842 | 0.030 |
Why?
|
Stillbirth | 1 | 2019 | 369 | 0.030 |
Why?
|
Affective Symptoms | 1 | 2019 | 417 | 0.030 |
Why?
|
Population | 1 | 2016 | 141 | 0.030 |
Why?
|
DNA | 1 | 1990 | 7189 | 0.030 |
Why?
|
HIV Infections | 1 | 2022 | 17347 | 0.030 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2013 | 4575 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10088 | 0.030 |
Why?
|
Child, Preschool | 5 | 2019 | 42224 | 0.030 |
Why?
|
Folic Acid | 1 | 2022 | 1323 | 0.030 |
Why?
|
Fetus | 1 | 2022 | 1864 | 0.030 |
Why?
|
Age Distribution | 2 | 2011 | 2871 | 0.030 |
Why?
|
Contracts | 1 | 2014 | 60 | 0.030 |
Why?
|
Sertraline | 1 | 2015 | 209 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 30002 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 820 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 1998 | 13385 | 0.030 |
Why?
|
Intelligence | 1 | 2019 | 922 | 0.030 |
Why?
|
Ontario | 1 | 2014 | 398 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2016 | 80674 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3134 | 0.030 |
Why?
|
Iron | 1 | 2022 | 1790 | 0.030 |
Why?
|
Phenotype | 1 | 2011 | 16575 | 0.030 |
Why?
|
Birth Rate | 1 | 2014 | 168 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1129 | 0.030 |
Why?
|
New Zealand | 1 | 2013 | 358 | 0.030 |
Why?
|
Hospitals, University | 1 | 2014 | 565 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 1990 | 4872 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 2113 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 22174 | 0.030 |
Why?
|
Citalopram | 1 | 2015 | 402 | 0.030 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2014 | 392 | 0.030 |
Why?
|
Students | 1 | 2022 | 1737 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2016 | 633 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2380 | 0.030 |
Why?
|
Recurrence | 1 | 2024 | 8457 | 0.020 |
Why?
|
Health Services Research | 1 | 2019 | 1807 | 0.020 |
Why?
|
Pleural Neoplasms | 1 | 1997 | 609 | 0.020 |
Why?
|
Fluoxetine | 1 | 2015 | 728 | 0.020 |
Why?
|
Health Policy | 1 | 2024 | 2679 | 0.020 |
Why?
|
Brain | 1 | 2018 | 27092 | 0.020 |
Why?
|
Telemedicine | 1 | 2009 | 3051 | 0.020 |
Why?
|
Psychopathology | 1 | 2014 | 432 | 0.020 |
Why?
|
Minnesota | 1 | 2011 | 337 | 0.020 |
Why?
|
Patient Preference | 1 | 2018 | 927 | 0.020 |
Why?
|
Mesothelioma | 1 | 1997 | 807 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2014 | 20119 | 0.020 |
Why?
|
Migraine without Aura | 1 | 2011 | 82 | 0.020 |
Why?
|
Pneumonectomy | 1 | 1997 | 1118 | 0.020 |
Why?
|
Alcohol-Related Disorders | 1 | 2012 | 238 | 0.020 |
Why?
|
Logistic Models | 2 | 2016 | 13249 | 0.020 |
Why?
|
Indoles | 1 | 1997 | 1830 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3410 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2598 | 0.020 |
Why?
|
Parenting | 1 | 2014 | 701 | 0.020 |
Why?
|
Migraine with Aura | 1 | 2011 | 204 | 0.020 |
Why?
|
Attention | 1 | 2019 | 2394 | 0.020 |
Why?
|
Personality Assessment | 1 | 2010 | 649 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3251 | 0.020 |
Why?
|
Vomiting | 1 | 2011 | 650 | 0.020 |
Why?
|
Psychology | 1 | 2010 | 356 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7400 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3571 | 0.020 |
Why?
|
Social Adjustment | 1 | 2010 | 632 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1662 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10756 | 0.020 |
Why?
|
Counseling | 1 | 2014 | 1536 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2010 | 7804 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 2019 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 2277 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 965 | 0.020 |
Why?
|
Aneuploidy | 1 | 1990 | 555 | 0.020 |
Why?
|
Motivation | 1 | 2016 | 2002 | 0.020 |
Why?
|
Epithelial Cells | 1 | 1997 | 3671 | 0.020 |
Why?
|
Body Height | 1 | 2012 | 1566 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2317 | 0.010 |
Why?
|
Microscopy | 1 | 1990 | 904 | 0.010 |
Why?
|
Diet | 1 | 2022 | 8048 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3885 | 0.010 |
Why?
|
Survival Rate | 1 | 1998 | 12728 | 0.010 |
Why?
|
Psychometrics | 1 | 2013 | 3061 | 0.010 |
Why?
|
Infant | 2 | 2019 | 36169 | 0.010 |
Why?
|
Cell Division | 1 | 1990 | 4451 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9652 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12474 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7966 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5869 | 0.010 |
Why?
|
Alcoholism | 1 | 2010 | 1973 | 0.010 |
Why?
|
Flow Cytometry | 1 | 1990 | 5871 | 0.010 |
Why?
|
Cost of Illness | 1 | 2009 | 1936 | 0.010 |
Why?
|
Mortality | 1 | 2009 | 2896 | 0.010 |
Why?
|
Sleep | 1 | 2014 | 4759 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1997 | 366 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2009 | 5493 | 0.010 |
Why?
|
Health Care Costs | 1 | 2009 | 3239 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3354 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12976 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1997 | 3057 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1997 | 9278 | 0.000 |
Why?
|
Mice | 1 | 1997 | 81326 | 0.000 |
Why?
|
Animals | 1 | 1997 | 168079 | 0.000 |
Why?
|